| Net earnings | |
| Depreciation and amortization | 149M |
| LIFO charge | 2M |
| Asset impairment and other charges | 2M |
| Gain on sale of assets | |
| Deferred income taxes | 16M |
| Stock-based compensation | 10M |
| Other | 9M |
| Changes in operating assets and liabilities | 19M |
| Net cash provided by operating activities | 278M |
| Proceeds from sale of assets | 1M |
| Purchases of property, plant and equipment | -110M |
| Other | 0 |
| Net cash used in investing activities | -115M |
| Proceeds from issuance of long-term debt | 58M |
| Payment of long-term debt and capital lease obligations | -211M |
| Dividends paid | |
| Other | |
| Net cash used in financing activities | -163M |
| Net decrease in cash and cash equivalents | 0 |
| Cash and cash equivalents at beginning of year | 57M |
| Cash and cash equivalents at the end of period | 57M |